Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ideggyogyaszati Szemle|June 6, 2018
[Role of peginterferon-β-1a in the therapy of multiplex sclerosis]Magdolna Simó, Anna Iljicsov
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 5, 2016
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis]Anna Iljicsov, Zsuzsanna Pál, Magdolna Simó
Multiple Sclerosis and Related Disorders|August 4, 2019
Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort studyKatalin Hegedüs, Judit Kárpáti, Anna Iljicsov, et al.
Ideggyogyaszati Szemle|June 6, 2018
[Experience with natalizumab-treatment at Semmelweis University]Barbara Gombos, Anna Iljicsov, Péter Barsi, et al.
Orvosi Hetilap|January 22, 2019
[Databases in neurological diseases: overview of international examples in multiple sclerosis]Anna Iljicsov, Magdolna Simó, Nárcisz Tegze, et al.
Ideggyogyaszati Szemle|March 28, 2026
[Paradigm shift in multiple sclerosis patient care at the Center of Neuro-immunology, Semmelweis University - data of 17 years]Anna Iljicsov, János Bíró, Zsolt Mezei, et al.
Orvosi Hetilap|January 22, 2019
[Multiple sclerosis in central Hungary: experiences and future possibilities of developing a local database]Anna Iljicsov, Magdolna Simó, Nárcisz Tegze, et al.
Plos One|February 1, 2012
In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosisErika Tátrai, Magdolna Simó, Anna Iljicsov, et al.
Ideggyogyaszati Szemle|November 7, 2012
Health status and costs of ambulatory patients with multiple sclerosis in HungaryMárta Péntek, László Gulácsi, Csilla Rózsa, et al.
Orvosi Hetilap|May 9, 2021
Age and gender characteristics of patients affected with multiple sclerosis in Hungary between 2004 and 2016Anna Iljicsov, Dániel Bereczki, Balázs Dobi, et al.
Pageof 2